In response to the "Traditional Chinese Medicine Development Plan" of the Fourteenth Five Year Development Plan, and to strengthen the departmental development of traditional Chinese medicine and clinical research, this paper systematically analyzes the scientific research progress in the inheritance and innovation of Chinese medicine in the past 20 years. The contents, include the research progress in clinical registration of traditional Chinese medicine at home and abroad in the past 20 years, the clinical research progress in the treatment of infectious diseases and chronic non infectious diseases, research and application progress of standardization of traditional Chinese medicine, research and application progress of new technologies in traditional Chinese medicine, and the "the Belt and Road Initiative" promoting the development of clinical research of traditional Chinese medicine in China. The results show that the clinical research and innovation achievements of Chinese medicine in the past 20 years have provided an important scientific and technological guarantee for inheritance, innovation and development of Chinese medicine. Chinese medicine has historically entered the mainstream medical system in the world and its international influence is significantly improving.
TAO Liyuan
,
FENG Yuting
,
SHANG Hongcai
. Analysis on innovation and development of clinical research of traditional Chinese medicine in the past 20 years[J]. Science & Technology Review, 2022
, 40(23)
: 24
-29
.
DOI: 10.3981/j.issn.1000-7857.2022.23.002
[1] 中共中央国务院关于促进中医药传承创新发展的意见[EB/OL].(2019-10-26)[2022-10-01]. http://www.gov.cn/zhengce/2019-10/26/content_5445336.htm.
[2] 国家中医药管理局.国家中医药管理局解读《"十四五"中医药发展规划》[EB/OL].(2022-03-29)[2022-10-01]. http://gcs.satcm.gov.cn/zhengcewenjian/2022-03-29/2569-5.html.
[3] 国务院办公厅.关于印发"十四五"中医药发展规划的通知[EB/OL].(2022-03-29)[2022-10-01]. http://www.satcm.gov.cn/guicaisi/zhengcewenjian/2022-03-29/25694.html.
[4] Cyranoski D. Why Chinese medicine is heading for clinics around the world[J]. Nature, 2018, 561(7724):448-450.
[5] Fears R, Griffin G E, Larhammar D, et al. Globalization of traditional Chinese medicine:What are the issues for ensuring evidence-based diagnosis and therapy[J]. Journal of Internal Medicine, 2020, 287(2):210-213.
[6] NIH National Center for Complementary and Integrative Health. Traditional Chinese Medicine:What you need to know[EB/OL].[2022-10-01]. https://nccih.nih.gov/health/whatiscam/chinesemed.html.
[7] Kemppainen L M, Kemppainen T T, Reippainen J A, et al. Use of complementary and alternative medicine in Europe:Health-related and sociodemographic determinants[J]. Scandinavian Journal of Public Health, 2018, 46(4):448-455.
[8] 中华中医药学会. 2020年度中医药十大学术进展[EB/OL].(2021-03-07)[2022-10-01]. http://www.satcm.gov.cn/hudongjiaoliu/guanfangweixin/2021-03-07/20626.html.
[9] Hu K, Guan W, Bi Y, et al. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019:A multicenter, prospective, randomized controlled trial[J]. Phytomedicine, 2021, 85:153242.
[10] Liang S, Fang M, Liang C, et al. Therapeutic effects and safety of oral Chinese patent medicine for COVID-19:A rapid systematic review and meta-analysis of randomized controlled trials[J]. Complementary Therapies in Medicine, 2021, 60:102744.
[11] 国家中医药管理局.重磅!2021年度中医药十大学术进展发布[EB/OL].(2022-01-13)[2022-10-01]. http://www.satcm.gov.cn/e/search/result/?searchid=51609.
[12] Lu L, Zhang Y, Tang X, et al. A neuroanatomical basis for electroacupuncture to drive the vagal-adrenal axis[J]. Nature, 2021, 598(7882):641-645.
[13] Lu L, Zhang Y, Tang X, et al. Evidence on acupuncture therapies is underused in clinical practice and health policy[J]. British Medical Journal, 2022, 376:e067475.
[14] Sun Y, Liu Y, Liu B, et al. Efficacy of acupuncture for chronic prostatitis/chronic pelvic pain syndrome:A Randomized Trial[J]. Annals of Internal Medicine, 2021,174(10):1357-1366.
[15] Xu S, Yu L, Luo X, et al. Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura:Multicentre, randomised clinical trial[J]. British Medical Journal, 2020, 368:m697.
[16] Qaseem A, Wilt T J, McLean R M, et al. Noninvasive treatments for acute, subacute, and chronic low back pain:A clinical practice guideline from the American college of physicians[J]. Annals of Internal Medicine, 2017, 166(7):514-530.
[17] 于博,陈方,杨阿强."一带一路"空间减灾研究与发展[J].科技导报, 2020, 38(16):53-57.
[18] 国家中医药管理局推进"一带一路"建设工作领导小组办公室.关于印发《推进中医药高质量融入共建"一带一路"发展规划(2021-2025年)》的通知[EB/OL].(2022-01-15)[2022-10-01]. http://ghs.satcm.gov.cn/zhengcewenjian/2022-01-15/24182.html.
